PONZ DE LEON, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 24397
EU - Europa 11702
AS - Asia 1606
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 3
OC - Oceania 1
Totale 37743
Nazione #
US - Stati Uniti d'America 24333
GB - Regno Unito 6150
SE - Svezia 1445
UA - Ucraina 1017
DE - Germania 983
IT - Italia 815
TR - Turchia 793
CN - Cina 625
FI - Finlandia 418
BG - Bulgaria 371
FR - Francia 183
BE - Belgio 103
IN - India 79
NL - Olanda 59
CA - Canada 54
IE - Irlanda 47
RU - Federazione Russa 35
KR - Corea 26
MY - Malesia 24
RO - Romania 21
VN - Vietnam 21
EU - Europa 11
CL - Cile 10
JP - Giappone 10
ES - Italia 9
BR - Brasile 7
IR - Iran 6
PL - Polonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BZ - Belize 5
CH - Svizzera 5
GR - Grecia 5
MX - Messico 5
SG - Singapore 5
AT - Austria 4
DK - Danimarca 4
BD - Bangladesh 3
CZ - Repubblica Ceca 3
LU - Lussemburgo 3
TH - Thailandia 3
HK - Hong Kong 2
LT - Lituania 2
MD - Moldavia 2
MK - Macedonia 2
RS - Serbia 2
SA - Arabia Saudita 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 37743
Città #
Southend 5521
Fairfield 3406
Woodbridge 2649
Jacksonville 2210
Houston 2183
Chandler 1835
Dearborn 1425
Ashburn 1381
Ann Arbor 1336
Seattle 1252
Wilmington 1236
Cambridge 1114
Nyköping 895
Princeton 486
Izmir 459
Sofia 371
Eugene 367
Modena 360
San Diego 351
Des Moines 282
Beijing 260
Bremen 113
Grafing 101
Falls Church 99
Brussels 89
London 82
Hefei 67
Helsinki 61
Milan 60
Norwalk 60
Boardman 56
Fremont 56
Kunming 52
Nanjing 47
Dublin 45
Philadelphia 39
Jinan 30
San Mateo 30
Ottawa 27
Redwood City 27
Verona 25
Auburn Hills 18
Toronto 18
Dong Ket 17
Indiana 17
Nanchang 17
Augusta 16
Chicago 16
New York 15
Guangzhou 14
Leawood 14
Mountain View 14
Waanrode 14
Fuzhou 13
Horia 12
Monmouth Junction 12
Brooklyn 11
Saint Petersburg 11
San Jose 11
Mumbai 9
Phoenix 9
Berlin 8
Edinburgh 8
Islington 8
Los Angeles 8
Wuhan 8
Yellow Springs 8
Chongqing 7
Cremona 7
Dallas 7
Rome 7
Shenyang 7
Zhengzhou 7
Bologna 6
Las Vegas 6
Reggio Nell'emilia 6
Arceto 5
Atlanta 5
Bangalore 5
Belize City 5
Chengdu 5
Clearwater 5
Hanover 5
Kraków 5
Monselice 5
Palermo 5
Quzhou 5
San Francisco 5
Timisoara 5
Xian 5
Amsterdam 4
Charlotte 4
Napoli 4
Rockville 4
Romainville 4
Shanghai 4
Shaoxing 4
Tokyo 4
Trieste 4
Vienna 4
Totale 31041
Nome #
Estimates of cancer burden in Italy 596
Attenuated polyposis of the large bowel: a morphologic and molecular approach 216
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 214
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 195
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 194
An unusual case of familial adenomatous polyposis with very early symptom occurrence 192
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 185
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 178
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 177
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 176
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 175
Clinical features of colorectal cancer patients in advanced age: a population-based approach 175
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 173
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 172
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 172
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 172
Aetiology of colorectal cancer and relevance of monogenic inheritance. 171
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. 171
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 167
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 166
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 165
Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma. 163
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 163
Alteration of drug metabolism during cholestasis in man 162
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. 162
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 162
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 161
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 161
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 161
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 160
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 159
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 159
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 156
Aberrant crypt foci in patients with colorectal cancer 156
Microsatellite instability and colorectal cancer prognosis. 156
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 154
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 153
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 153
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 152
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. 152
Peutz-Jeghers syndrome: a systematic review and recommendations for management 151
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome. 150
Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening. 150
Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme 150
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 150
Cholesterol esterase activity of human intestinal mucosa 148
Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. 146
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 146
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 146
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 145
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 145
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 144
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 144
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 143
Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study 143
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 143
Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2 142
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 142
Variations in the survival adult cancer patients in Italy 142
Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients 142
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 141
Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm? 141
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 140
Effects of acute changes of bile acid pool composition on biliary lipid secretion 139
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis. 139
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 139
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 138
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 138
Integrated analysis of unclassified variants in mismatch repair genes. 138
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 138
K-ras and p53 mutations in human colorectal aberrant crypt foci 137
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 137
Identification of Lynch syndrome among patients with colorectal cancer. 137
Clinical and biologic features of adenomatosis coli in Northern Italy 137
Attività citoproliferativa della mucosa rettale in pazienti con neoplasie del grosso intestino 137
Bile lipid composition and bile acid pool size in diabetes 136
Clinical and molecular characterization of colorectal cancer in young Moroccan patients 136
ANTIOXIDANT VITAMINS OR LACTULOSE AS CHEMOPREVENTIVE AGENTS FOR COLORECTAL CANCER 136
Surgical management of the duodenal manifestations of familial adenomatous polyposis 135
Physiological factors influencing serum bile acid levels 135
Alteration of drug metabolism in Gilbert's syndrome 134
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 134
What should we advise about alcohol consumption. 134
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events 134
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 134
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 133
Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome. 133
Neutrophil gelatinase-associated lipocalin: A new prognostic marker in stage i colorectal carcinoma? 133
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 133
The influence of age on colonic epithelial cell proliferation 132
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 132
The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis 132
MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria 132
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 132
Estimates of cancer burden in Emilia-Romagna 132
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. 131
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 131
Regional inequalities in cancer care persist in Italy and can influence survival. 131
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 130
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 130
Totale 15520
Categoria #
all - tutte 80497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201836 0000 00 00 00036
2018/20195545 83459122316 435322 47136 26944212001390
2019/20209522 891604324535 10211388 1578821 1158304538360
2020/20216537 702235561626 865399 641843 276755352282
2021/20225836 154907466488 134285 358273 6333921072674
2022/20235059 686528321499 628951 90464 6244620517
Totale 38007